Latest Growth Strategy News

Almonty Industries has secured an exclusive offtake agreement with South Korea’s SeAH Group to supply 100% of molybdenum from its Sangdong project, underpinning financial stability and strengthening local supply chains.

AML3D Limited has reported a strong December quarter marked by significant defense contract completions, a $30 million capital raise, and strategic expansion into the US and European markets. The company is poised for accelerated growth, underpinned by a major US Navy funding boost and new sector entries.

Murray Cod Australia Ltd has secured a $43 million funding package from Westpac, advancing its Stanbridge site construction and expanding its biomass. The company also initiated exports to Thailand and is progressing towards entry into the Chinese market.

Resolute Mining delivered a solid 2024 with record cash flows and slightly higher gold production, but faces rising costs from Mali’s new Mining Code and a $160 million government settlement. The company plans lower 2025 output as Mako mining winds down, focusing on cash flow and exploration.

NEXION Group reported a robust 30% increase in cash receipts for Q2 FY25, driven by strong sales growth and new satellite sector contracts. The company is actively expanding its footprint in Southeast Asia while funding ongoing M&A activities through convertible notes.

Resource Mining Corporation reports promising copper-gold exploration results at its Mpanda project in Tanzania, secures $1 million in loan funding, and gains an option to acquire a 70% stake in a Saudi Arabia joint venture.

IGO's December quarter report reveals robust performance at Greenbushes lithium mine but significant setbacks at Kwinana and Nova, culminating in a $79 million EBITDA loss and a strategic halt on Kwinana’s Plant 2.

NeuroScientific Biopharmaceuticals has initiated critical IND-enabling studies for its glaucoma drug candidate EmtinB, backed by a solid cash position of A$4.5 million as of December 2024. Preliminary melanin binding results are shaping the path toward first-in-human trials.

Austral Gold reported an 8.5% production increase in Q4 2024 alongside significant cost reductions, though full-year output fell short of forecasts due to equipment delays. The company sets ambitious 2025 targets, supported by a new toll processing deal and plant refurbishment financing.

Acrux Limited has launched its Nitroglycerin 0.4% Ointment and successfully raised nearly $4 million, positioning the specialty pharma company for sustained revenue growth.

Credit Corp Group Limited has reported a remarkable turnaround for the half-year ended 31 December 2024, posting a 464% increase in profit after tax to $44.1 million and a 45% rise in revenue to $271.5 million. The company also declared a fully franked interim dividend of 32 cents per share, signalling confidence in ongoing growth.

Capricorn Metals delivered a robust December quarter with rising gold production, record cash flow, and strategic expansions, positioning itself strongly for FY25 targets.